Sep 12, 2022 / 12:10PM GMT
Terence C. Flynn - Morgan Stanley, Research Division - Equity Analyst
Great. Good morning, everybody. Thanks for joining us today. I'm Terence Flynn, the pharma analyst at Morgan Stanley. Just first on disclosures. For important disclosures, please see the Morgan Stanley research website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
This morning, I'm very pleased to be hosting Bristol-Myers. Today from the company, we have Chris Boerner, who is Executive Vice President and Chief Commercial Officer. Thanks for joining us, Chris.
Christopher S. Boerner - Bristol-Myers Squibb Company - Executive VP & Chief Commercialization Officer
Happy to be here.
Questions and Answers:
Terence C. Flynn - Morgan Stanley, Research Division - Equity AnalystSo before I get into the congratulations on deucrava or SOTYKTU, which we are just